ABCG2 and breast cancer: The ABCG2 C421A polymorphism was related to the preoperative neoadjuvant chemotherapeutic response of BC patients, and the ABCG2 G34A genotypes were associated with the prognostic response in ER positive or PR positive patients with anthracycline-based chemotherapy.